CLAREMONT, Calif., Dec. 9 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has announced the launch of an orphan drug workshop series--an opportunity for biotechnology companies, pharmaceutical firms, academics and other interested parties to spend two days creating applications for orphan status designation, under the guidance of staff from FDA's Office of Orphan Products Development (OOPD). The first workshop is planned for Feb. 25-26, 2010, hosted by the Center for Rare Disease Therapies at Keck Graduate Institute (KGI) in Claremont, Calif.
The intent of this workshop is to simplify and demystify entry into orphan drug development. Each attendee must come prepared to work on an application for a particular drug or therapy.
There will be an introductory presentation, but most of the time over the two-day period will be spent writing an application for orphan designation for specific products, which will be submitted at the close of the workshop.
Having a product designated an "orphan" provides important incentives and can be done at any time prior to submission of a marketing application. To receive orphan designation, the submitting organization must convince the FDA-OOPD that the proposed drug is targeted toward a rare disease (one with a patient population of fewer than 200,000 people) and holds promise for treating the rare disease.
For information about the workshops, contact Lucienne Nelson at email@example.com or 301-827-3666.
The National Organization for Rare Disorders is partnering with FDA on these workshops, the second of which will be held at the University of Minnesota on Aug. 3-4, 2010.
Educating the future leaders of the bioscience industry, Keck Graduate Institute (KGI) offers an interdisciplinary graduate education through its Master of Bioscience (MBS), Postdoctoral Professional Masters in Bioscience Management (PPMBS), PhD programs, and other degrees. Using team-based learning and real-world projects, KGI's innovative curriculum seamlessly combines applied life sciences, bioengineering, bioethics and business management. KGI also has a robust research program concentrating on the translation of basic discoveries in the life sciences into applications that can benefit society. KGI is a member of The Claremont Colleges, located in Claremont, California.
Keck Graduate Institute of Applied Life Sciences is dedicated to education and research aimed at translating into practice, for the benefit of society, the power and potential of the life sciences.
SOURCE Keck Graduate Institute
|SOURCE Keck Graduate Institute|
Copyright©2009 PR Newswire.
All rights reserved